These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 13663184)

  • 1. Use of a calcium chelating agent (NaEDTA) in cardiac arrhythmias.
    COHEN BD; SPRITZ N; LUBASH GD; RUBIN AL
    Circulation; 1959 Jun; 19(6):918-27. PubMed ID: 13663184
    [No Abstract]   [Full Text] [Related]  

  • 2. Calcium, chelates, and digitalis, A clinical Study.
    ELIOT RS; BLOUNT SG
    Am Heart J; 1961 Jul; 62():7-21. PubMed ID: 13726368
    [No Abstract]   [Full Text] [Related]  

  • 3. Myocardial responses to chelation.
    SOFFER A; TORIBARA T; SAYMAN A
    Br Heart J; 1961 Nov; 23(6):690-4. PubMed ID: 13914780
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment of acute hypercalcaemia with a chelating agent.
    BARON DN
    Proc R Soc Med; 1956 Oct; 49(10):728. PubMed ID: 13379383
    [No Abstract]   [Full Text] [Related]  

  • 5. Use of the chelating agent, EDTA, in digitalis intoxication and cardiac arrhythmias.
    SURAWICZ B
    Prog Cardiovasc Dis; 1960 Mar; 2():432-43. PubMed ID: 13835766
    [No Abstract]   [Full Text] [Related]  

  • 6. [Electrolytes and arrhythmia].
    HINOHARA S; IGARASHI M; KATAYAMA F
    Naika; 1962 Aug; 10():245-53. PubMed ID: 13907551
    [No Abstract]   [Full Text] [Related]  

  • 7. [Biological study of a chelating agent with calcium affinity in the field of otology].
    CHEVANCE LG
    Ann Otolaryngol; 1958 Dec; 75(12):930-7. PubMed ID: 13617798
    [No Abstract]   [Full Text] [Related]  

  • 8. The effect of an intravenous chelating agent, edathamil disodium (Na 2-EDTA), in 3 cases of sarcoidosis.
    RUKAVINA JG; ORKIN M; LYNCH FW
    J Invest Dermatol; 1958 Nov; 31(5):259-62. PubMed ID: 13598931
    [No Abstract]   [Full Text] [Related]  

  • 9. The effect of calcium chelation on cardiac arrhythmias and conduction distrubances.
    JICK S; KARSH R
    Am J Cardiol; 1959 Sep; 4():287-93. PubMed ID: 14407278
    [No Abstract]   [Full Text] [Related]  

  • 10. [Employment of chelating agents of the Calcium E.D.T.A. type during the course of various excessive blood iron conditions].
    LAMACHE A; BOUREL M; VIVIEN P; CORMIER M; LENOIR P; AZARD C; DELAHAYE D
    Sem Med Prof Med Soc; 1957 Feb; 33(7):295-8. PubMed ID: 13421822
    [No Abstract]   [Full Text] [Related]  

  • 11. Treatment of digitalis toxicity by chelation of serum calcium.
    GUBNER RS; KALLMAN H
    Am J Med Sci; 1957 Aug; 234(2):136-44. PubMed ID: 13444264
    [No Abstract]   [Full Text] [Related]  

  • 12. Chelation therapy for arteriosclerosis.
    Soffer A
    JAMA; 1975 Sep; 233(11):1206-7. PubMed ID: 808649
    [No Abstract]   [Full Text] [Related]  

  • 13. [The anti-arrhythmic activity of EDTA tetrabutylamide].
    Gendenshteĭn EI
    Biull Eksp Biol Med; 1966 Jul; 62(7):71-3. PubMed ID: 4988482
    [No Abstract]   [Full Text] [Related]  

  • 14. Lead poisoning in childhood treated by the subcutaneous administration of a chelating agent.
    O'DONOHOE NV
    Arch Dis Child; 1956 Aug; 31(158):321-3. PubMed ID: 13363476
    [No Abstract]   [Full Text] [Related]  

  • 15. The use of chelating agents in the treatment of acute porphyria.
    GALAMBOS JT; PEACOCK LB
    Ann Intern Med; 1959 Apr; 50(4):1056-61. PubMed ID: 13637577
    [No Abstract]   [Full Text] [Related]  

  • 16. [Sclerodactyly with digital and pre-rotular calcinosis (Thibierge-Weissenbach syndrome) preceded by Renaud's syndrome; results of treatment with a chelating agent (sodium salt of edathamil)].
    NICK J; CONTAMIN F; HARL JM; MORIN P
    Bull Mem Soc Med Hop Paris; 1957 Feb 1-15; 73(4-6):169-74. PubMed ID: 13413679
    [No Abstract]   [Full Text] [Related]  

  • 17. [Chelation - therapeutic applications].
    Perrault M; Clavel B
    Rev Pathol Gen Physiol Clin; 1958 Apr; 58(697):519-49 discussion 549-53. PubMed ID: 13579827
    [No Abstract]   [Full Text] [Related]  

  • 18. [Chelating agents in ophthalmology].
    ROUHER F
    Bull Soc Ophtalmol Fr; 1958 Feb; 2():104-7. PubMed ID: 13561041
    [No Abstract]   [Full Text] [Related]  

  • 19. Therapy of acute, chronic and mixed hepatic porphyria patients with chelating agents.
    PETERS HA; EICHMAN PL; REESE HH
    Neurology; 1958 Aug; 8(8):621-32. PubMed ID: 13566414
    [No Abstract]   [Full Text] [Related]  

  • 20. Chelating agents in the therapy of beryllium poisoning.
    CASH R; SHAPIRO RI; LEVY SH; HOPKINS SM
    N Engl J Med; 1959 Apr; 260(14):683-6. PubMed ID: 13644567
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.